Pluronic® F127-based systemic vaccine delivery systems
- 1 June 2004
- Vol. 22 (19) , 2396-2405
- https://doi.org/10.1016/j.vaccine.2003.11.064
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in miceBone Marrow Transplantation, 2003
- ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoidVaccine, 2001
- Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine AntigensInfection and Immunity, 2000
- Long-term protection of mice against Leishmania major with a synthetic peptide vaccineVaccine, 1999
- Evaluation of Pluronic F127-Based Sustained-Release Ocular Delivery Systems for Pilocarpine using the Albino Rabbit Eye ModelJournal of Pharmaceutical Sciences, 1998
- PrefaceAdvanced Drug Delivery Reviews, 1998
- In Vitro Evaluation of Pluronic F127-Based Controlled-Release Ocular Delivery Systems for PilocarpineJournal of Pharmaceutical Sciences, 1998
- Acute and chronic response to vanadium following two methods of streptozotocin-diabetes inductionCanadian Journal of Physiology and Pharmacology, 1997
- The polyoxyethylene/polyoxypropylene block co‐polymer Poloxamer‐407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrowFEBS Letters, 1992
- The Adjuvant Activity of Nonionic Block Polymer SurfactantsScandinavian Journal of Immunology, 1986